- Healthcare Realty Trust reported third quarter revenue of $277.6 million, down 6.8% year on year, with EPS of $0.42 and funds from operations of $145.9 million, both above analyst expectations, along with updated full year FFO guidance of $1.65 to $1.67 per share.
- The real estate investment trust combined stronger than forecasted operating metrics with active portfolio reshaping through $211 million of joint venture acquisitions, $68 million of disposals, and a declared $0.24 per share common dividend payable in November 2026.
- We will look at how Healthcare Realty Trust's raised full year FFO guidance reshapes the investment narrative around its medical office exposure.
Scan beyond Healthcare Realty Trust and line up other real estate income plays with resilient cash generation using our curated list of solid balance sheet and fundamentals (22 results)
What Is Healthcare Realty Trust's Investment Narrative?
Owning Healthcare Realty Trust is really a call on medical office buildings staying useful cash flow assets rather than trading vehicles. The third quarter print, with revenue of $277.6 million and FFO of $145.9 million above expectations, suggests operations across its outpatient portfolio are holding up even as rental and interest income eased year on year. The updated full year FFO outlook of $1.65 to $1.67 per share indicates that management sees the current leasing, expense and interest cost picture as manageable in the near term.
The bigger swing factor is execution on the capital program. Healthcare Realty Trust is actively reshaping its footprint, with $211 million of joint venture acquisitions and $68 million of sales in the quarter, all while carrying a common dividend that recent analysis flagged as not well covered by free cash flows. That mix of high capital intensity and a 5.3% yield means the raised FFO guidance is helpful for short term confidence but does not settle questions about how much financial flexibility exists if conditions tighten.
Even so, one issue around how Healthcare Realty Trust funds this whole plan tends to get less attention until you consider ...
There's only one way to know the right time to buy, sell or hold Healthcare Realty Trust. Head to Simply Wall St's company report for the latest analysis of Healthcare Realty Trust's Fair Value.
Exploring Other Perspectives
Two fair value estimates from the Simply Wall St Community span roughly US$21.08 to US$31.72 per share for Healthcare Realty Trust, which already shows how far opinions can stretch. Those views were formed before the October 2026 earnings update, so you should weigh them against fresh FFO guidance and portfolio churn.
Explore another Healthcare Realty Trust fair value estimate, including one that suggests as much as 75% upside from the current price.
Reach Your Own Conclusion
Don't just follow the ticker; dig into the data and build a conviction that's truly your own.
- A great starting point for your Healthcare Realty Trust research is our analysis highlighting 2 key rewards and 2 important warning signs that could impact your investment decision.
- See our latest analysis for Healthcare Realty Trust. The report includes a comprehensive fundamental analysis summarized in a single visual, the Snowflake, making it easy to evaluate Healthcare Realty Trust's overall financial health at a glance.
Looking for more investment ideas beyond Healthcare Realty Trust?
Once you have a handle on Healthcare Realty Trust, it can help to widen the lens and compare it with other businesses that share similar income or balance sheet profiles. The Simply Wall St Screener lets you do that quickly by filtering for the traits that matter most to you, whether that is financial resilience, income potential, or mispriced quality.
- If capital preservation and steadier risk profiles sit high on your list, consider screening for 30 resilient stocks with low risk scores that might better match your comfort level.
- Income focused readers can zero in on reliable cash distributions by reviewing 7 dividend fortresses that combine higher yields with supporting fundamentals.
- For those hunting for mispriced quality, it may be worth lining up 18 high quality undiscovered gems that pair solid financials with less market attention.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com